See also this year's filing and all EDGAR filings for this company.
PDF Report 0001236997_2017_Counterpath_CORP.pdf
Logs
warning | The stock price does not exist | industry.us_generic | {} |
warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
warning | No stock price available | subcommand.plot | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001236997')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001236997, Counterpath CORP
xvar | xval | |
---|---|---|
0 | LiabilitiesCurrent | 3,815,705 |
1 | LongTermDebt | 0 |
2 | remainder_Liabilities | 45,942 |
3 | IntangibleAssets | 7,001,228 |
4 | AssetsNoncurrent | 174,811 |
5 | AssetsCurrent | 5,553,661 |
6 | PropertyPlantAndEquipmentNet | 142,563 |
7 | remainder_Assets | 93,868 |
8 | SellingAndMarketingExpense | 4,145,351 |
9 | GeneralAndAdministrativeExpense | 3,373,674 |
10 | ResearchAndDevelopmentExpense | 4,737,055 |
11 | remainder_Expenses | 1,669,397 |
12 | remainder_Revenues | 11,081,358 |
13 | remainder_NetIncome | 152,524 |
14 | remainder_ComprehensiveNetIncome | -550,468 |
yvar | yval | |
---|---|---|
0 | Liabilities | 3,861,647 |
1 | Assets | 12,966,131 |
2 | Expenses | 13,925,477 |
3 | Revenues | 11,081,358 |
4 | StockholdersEquity | 9,104,484 |
5 | NetIncome | -2,691,595 |
6 | ComprehensiveNetIncome | -3,242,063 |
7 | BaseVar | 21,268,802 |
8 | EconomicCapitalRatiobeforeLimitedLiability | 3.19 |
9 | EconomicCapitalRatio | 4.67 |